#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Conjunctivitis allergic Round cell liposarcoma Deafness bilateral Congenital cystic kidney disease Oesophageal atresia Short-bowel syndrome Aspergillus infection Phenylketonuria Acute myeloid leukaemia recurrent Synovial sarcoma recurrent Fibrosarcoma Breast angiosarcoma metastatic Meningitis meningococcal Renal disorder Haemophagocytic lymphohistiocytosis More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia recurrent – Life with Disease Chondrosarcoma metastatic SAPHO syndrome Alveolar rhabdomyosarcoma – Basic Information Cystic fibrosis – Diagnostics Medulloblastoma recurrent – Treatment Testicular leiomyosarcoma – Trials in Disease Acquired haemophilia Glycogen storage disease type II – Treatment Mucopolysaccharidosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Domvanalimab Etamsylate Toripalimab ALXN2420 Tilmanocept Apalutamide Ptc518 Wt1/Il15/Il15Ra Mrna Dc Olodaterol Enomimeran Bi 765845 [68GA]GA-NOTA-AE105 Chlorpromazine Mb-Cart20.1 Casirivimab Sufentanil NERANDOMILAST Pentixather Glycerol Tub-040 More therapies…

    Learn about Your Condition

    Hyperhidrosis Nasopharyngeal cancer Bacterial infection Rabies Endometrial adenocarcinoma Weaning failure Breast cancer male Atopic keratoconjunctivitis Adenosquamous cell lung cancer Narcolepsy Electrocorticogram Brain neoplasm malignant Coronary artery bypass Spinal cord injury Graft versus host disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Fondation A De Rothschild

Fondation A De Rothschild

29 Rue Manin, Paris, 75019, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of Satralizumab for Patients with Moderate-to-Severe Thyroid Eye Disease

    Not recruiting

    3 1 1
    France Poland Portugal Spain

  • Study on the Effects of Ecopipam Hydrochloride for Children and Adolescents with Tourette’s Disorder

    Not recruiting

    3 1
    Investigated Diseases:
    • Tourette’s disorder
    Investigated Drugs:
    • Ecopipam Hydrochloride
    Bulgaria Denmark France Germany Hungary Italy +3

  • Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Clopidogrel
    • Milvexian
    • Acetylsalicylic Acid
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study on the Long-Term Safety of Ecopipam Hydrochloride Tablets for Children, Adolescents, and Adults with Tourette’s Disorder

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Tourette’s disorder
    Investigated Drugs:
    • Ecopipam Hydrochloride
    Bulgaria Denmark France Germany Hungary Italy +2

  • Study on the Safety of Avacincaptad Pegol for Patients with Geographic Atrophy Who Completed a Previous Study

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Investigated Drugs:
    • Avacincaptad Pegol
    • Fluorescein Sodium
    Austria Belgium Croatia Czechia France Germany +4

  • Study on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Diabetic retinal oedema
    • Macular oedema
    Investigated Drugs:
    • Eye103
    • Fluorescein Sodium
    • Ranibizumab
    Austria Croatia Czechia France Germany Hungary +6

  • Study of AMG 732 injection compared to placebo in patients with moderate to severe thyroid eye disease

    Not recruiting

    2 1
    Investigated Drugs:
    • AMG 732
    France Germany Greece Italy Poland Spain
Previous Page
1 … 6 7 8

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!